Abstract
We all know well that during the last 30 years not a single new medication has been discovered which would present a mode of action different from that the established medications for the therapy of diabetes mellitus. It is characteristic that postprandial hyperglycemia in type I diabetics is particularly difficult to compensated since the increase of blood glucose cannot by synchronized with the high levels of exogenously administered insulin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Raptis S, Dimitriadis G, Karaiskos K, Rosenthal J, Zoupas C, Moulopoulos S (1980) Effects of an α-glucosidase inhibitor of insulin requirements and catecholamine levels assessed by the artificial β-cell. Diabetes 29 (suppl 2): 41A
Raptis S, Dimitriadis G, Etzrodt H, Karaiskos K, Hadjidakis D, Rosenthal J, Zoupas C, Diamentopoulos E (1982) The effects of acarbose treatment on release of pancreatic and gastrointestinal hormones in man. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 210–215
Dimitriadis G, Karaiskos K, Raptis S (1986) Effects of prolonged (6 months) α-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus. Horm Metab Res 18:253–255
Beyer J, Schulz G, Jäger H, Krause U, Cordes U (1981) Improvement of carbohydrate tolerance in insulin-dependent diabetics after administration of an α-glucosidase inhibitor demonstrated by artificial pancreas. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 451–454
Petzoldt R, Vrahimis J, Fink HD, Sauer H (1981) Effect of a single dose of acarbose on postprandial blood glucose values in insulin-dependent diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 427–432
Katsimantis D, Hillebrand I, Vikeli D, Lambropoulou V, Papachristou C (1981) Acarbose treatment in hospitalized diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 340–343
Aubell R, Boehme K, Berchtold P (1983) Blood glucose concentrations and glycosuria during and after one year of acarbose treatment. Arzneimittelforschung 33 (II), 9:1314–1318
Schumann F, Janssen K, Aubell R, Christi HL (1981) Acarbose in diabetic out-patient treatment: results of a 3-month study. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 367–372
Willms B, Sachse G (1981) Short-term effects of acarbose in insulin-treated diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 471–473
Hillebrand I, Reis HE, Boehme K, Jahnke K (1981) The effect of the α-glucosidase acarbose on the urinary glucose excretion in poorly controlled insulin-dependent diabetics. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 482–485
Edmonds ME, Doddridge M, John PN, White JM, Watkins PJ (1981) Acarbose and postprandial glycaemia in the home blood-glucose profile. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 402–405
Henrichs IA, Heinze E, Kohne E, Teller WM (1981) Improved management of juvenile diabetes by acarbose. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 490–493
Dimitriadis G, Tessari P, Go V, Gerich J (1985) α-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus. Metabolism 34:261–265
Dimitriadis G, Tessari P, Go V, Gerich J (1982) Effects of disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man. Metabolism 31:841–843
Puls W, Keup U, Krause H, Thomas G, Hoffmeister F (1982) The concept of glucosidase inhibition and its pharmacological realization. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 210–215
Caspary W, Lembcke W, Creutzfeldt W (1982) Inhibition of human intestinal α-glucosidase activity by acarbose and clinical consequences. In: Creutzfeldt W (ed) Acarbose: effects on carbohydrate and fat metabolism. Excerpta Medica, Amsterdam, pp 27–37
Jenkins D (1982) Lente carbohydrate: a never approach to the dietary management of diabetes. Diabetes Care 5:634–641
Jenkins D, Ghafari H, Wolever T, Taxlor R, Jenkins A, Barker H, Fielden H, Bowling A (1982) Relationship between rate of digestion of foods and postprandial glycaemia. Diabetologia 22:450–455
Dimitriadis G, Gerich J (1983) Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374–377
Pfeiffer EF, Thum C, Clemens AH (1974) The artificial beta-cell. A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 6:339–342
Jenkins D, Taylor R, Goff D, Fielden H, Misiewicz J, Sarson D, Bloom S, Alberti K (1981) Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 30:951–954
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Raptis, S., Dimitriadis, G., Hadjidakis, D. (1988). Acarbose Treatment in Insulin-Dependent (Type I) Diabetes Mellitus. In: Creutzfeldt, W. (eds) Acarbose for the Treatment of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73583-7_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-73583-7_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19145-2
Online ISBN: 978-3-642-73583-7
eBook Packages: Springer Book Archive